These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27424179)

  • 1. Enhanced expression of PD-L1 in oral squamous cell carcinoma-derived CD11b(+)Gr-1(+) cells and its contribution to immunosuppressive activity.
    Fuse H; Tomihara K; Heshiki W; Yamazaki M; Akyu-Takei R; Tachinami H; Furukawa KI; Sakurai K; Rouwan M; Noguchi M
    Oral Oncol; 2016 Aug; 59():20-29. PubMed ID: 27424179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.
    Liu Y; Zeng B; Zhang Z; Zhang Y; Yang R
    Clin Immunol; 2008 Dec; 129(3):471-81. PubMed ID: 18790673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.
    Yang R; Cai Z; Zhang Y; Yutzy WH; Roby KF; Roden RB
    Cancer Res; 2006 Jul; 66(13):6807-15. PubMed ID: 16818658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
    Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
    Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonuclear Myeloid-Derived Cells That Contribute to the Immune Paralysis Are Generated in the Early Phase of Sepsis via PD-1/PD-L1 Pathway.
    Ao X; Yang Y; Okiji T; Azuma M; Nagai S
    Infect Immun; 2021 May; 89(6):. PubMed ID: 33753411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade.
    Tachinami H; Nishii N; Xia Y; Kashima Y; Ohno T; Nagai S; Li L; Lau W; Tomihara K; Noguchi M; Azuma M
    Oral Oncol; 2019 Apr; 91():21-28. PubMed ID: 30926058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro.
    Han EC; Lee J; Ryu SW; Choi C
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multipotency of CD11bhighGr-1+ immature myeloid cells accumulating in oral squamous cell carcinoma-bearing mice.
    Tanaka K; Jinhua P; Omura K; Azuma M
    Oral Oncol; 2007 Jul; 43(6):586-92. PubMed ID: 16996780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells.
    Stewart TJ; Liewehr DJ; Steinberg SM; Greeneltch KM; Abrams SI
    J Immunol; 2009 Jul; 183(1):117-28. PubMed ID: 19542426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages.
    Jiang C; Yuan F; Wang J; Wu L
    Immunobiology; 2017 Apr; 222(4):651-657. PubMed ID: 28017495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells.
    Prima V; Kaliberova LN; Kaliberov S; Curiel DT; Kusmartsev S
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1117-1122. PubMed ID: 28096371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
    Kapanadze T; Medina-Echeverz J; Gamrekelashvili J; Weiss JM; Wiltrout RH; Kapoor V; Hawk N; Terabe M; Berzofsky JA; Manns MP; Wang E; Marincola FM; Korangy F; Greten TF
    Eur J Immunol; 2015 Apr; 45(4):1148-58. PubMed ID: 25616156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling.
    Fleming V; Hu X; Weller C; Weber R; Groth C; Riester Z; Hüser L; Sun Q; Nagibin V; Kirschning C; Bronte V; Utikal J; Altevogt P; Umansky V
    Cancer Res; 2019 Sep; 79(18):4715-4728. PubMed ID: 31337655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
    Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
    Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1.
    Lee Y; Shin JH; Longmire M; Wang H; Kohrt HE; Chang HY; Sunwoo JB
    Clin Cancer Res; 2016 Jul; 22(14):3571-81. PubMed ID: 26864211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.
    Chen J; Feng Y; Lu L; Wang H; Dai L; Li Y; Zhang P
    Immunobiology; 2012 Apr; 217(4):385-93. PubMed ID: 22204817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4
    Mattox AK; Lee J; Westra WH; Pierce RH; Ghossein R; Faquin WC; Diefenbach TJ; Morris LG; Lin DT; Wirth LJ; Lefranc-Torres A; Ishida E; Chakravarty PD; Johnson L; Zeng YC; Chen H; Poznansky MC; Iyengar NM; Pai SI
    Cancer Res; 2017 Nov; 77(22):6365-6374. PubMed ID: 28947422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.
    Fujimura T; Ring S; Umansky V; Mahnke K; Enk AH
    J Invest Dermatol; 2012 Apr; 132(4):1239-46. PubMed ID: 22189788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenteric lymph node CD11b
    Shiokawa A; Kotaki R; Takano T; Nakajima-Adachi H; Hachimura S
    Immunology; 2017 Sep; 152(1):52-64. PubMed ID: 28423181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Areca nut extracts enhance the development of CD11b(+) Gr-1(+) cells with the characteristics of myeloid-derived suppressor cells in antigen-stimulated mice.
    Wang CC; Lin HL; Liang HJ; Jan TR
    J Oral Pathol Med; 2011 Nov; 40(10):769-77. PubMed ID: 21481006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.